Back to Search
HOLLY GALLION, M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1356649784Individual
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
20769(KY)
Research & Publications (20)
Diagnosis of Trichomonas vaginalis in female children and adolescents evaluated for possible sexual abuse: a comparison of the InPouch TV culture method and wet mount microscopy.
PMID 19576816·J Pediatr Adolesc Gynecol·2009
4-observational
Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer.
PMID 18640939·J Clin Oncol·2008
3-trial
Expression and activity of taxane-metabolizing enzymes in ovarian tumors.
PMID 18063021·Gynecol Oncol·2008
8-other
Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
PMID 17850853·Gynecol Oncol·2007
8-other
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
PMID 17574073·Gynecol Oncol·2007
3-trial
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
PMID 17208284·Gynecol Oncol·2007
8-other
Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
PMID 17150247·Gynecol Oncol·2007
3-trial
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
PMID 17001661·Cancer·2006
8-other
High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
PMID 15899382·Cancer Genet Cytogenet·2005
8-other
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
PMID 15721404·Gynecol Oncol·2005
3-trial
Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix.
PMID 15493357·Cancer Invest·2004
8-other
CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
PMID 15297171·Gynecol Oncol·2004
3-trial
Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study.
PMID 15277255·Ann Oncol·2004
3-trial
Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
PMID 14551299·J Clin Oncol·2003
3-trial
Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms.
PMID 14529660·Gynecol Oncol·2003
3-trial
Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.
PMID 11972384·Gynecol Oncol·2002
8-other
BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study.
PMID 11733976·Gynecol Oncol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 339 WHITNEY HENDRICKSON BLDG 800 ROSE STREET
LEXINGTON, KY 40536 - Phone
- (859) 323-5553
Quick Facts
- NPI
- 1356649784
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile